Genetic ablation of Nhe1 resulted in reduced reactive astrogliosis, microglial activation, cerebral infraction, white matter lesions, and improved neurological function in mouse model of ischemic stroke (Begum et al., 2018; Song et al., 2018). This evidence concerns the gene SLC9A1 and ischemic stroke.